228 related articles for article (PubMed ID: 28367859)
1. Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
Oda S; Utsunomiya D; Nakaura T; Yuki H; Kidoh M; Morita K; Takashio S; Yamamuro M; Izumiya Y; Hirakawa K; Ishida T; Tsujita K; Ueda M; Yamashita T; Ando Y; Hata H; Yamashita Y
Circ J; 2017 Jun; 81(7):1014-1021. PubMed ID: 28367859
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
[TBL] [Abstract][Full Text] [Related]
3. Left atrial function in cardiac amyloidosis.
Di Bella G; Minutoli F; Madaffari A; Mazzeo A; Russo M; Donato R; Zito C; Aquaro GD; Piccione MC; Pedri S; Vita G; Pingitore A; Carerj S
J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):113-21. PubMed ID: 25222078
[TBL] [Abstract][Full Text] [Related]
4. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of systolic and diastolic function in patients with LGE negative systemic amyloidosis using CMR.
Kuetting DL; Homsi R; Sprinkart AM; Luetkens J; Thomas DK; Schild HH; Dabir D
Int J Cardiol; 2017 Apr; 232():336-341. PubMed ID: 28153537
[TBL] [Abstract][Full Text] [Related]
6. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
7. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
[TBL] [Abstract][Full Text] [Related]
8. Regional Amyloid Burden Differences Evaluated Using Quantitative Cardiac MRI in Patients with Cardiac Amyloidosis.
Kim JY; Hong YJ; Han K; Lee HJ; Hur J; Kim YJ; Choi BW
Korean J Radiol; 2021 Jun; 22(6):880-889. PubMed ID: 33686816
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of cardiovascular magnetic resonance for patients with suspected cardiac amyloidosis: a systematic review and meta-analysis.
Zhao L; Tian Z; Fang Q
BMC Cardiovasc Disord; 2016 Jun; 16():129. PubMed ID: 27267362
[TBL] [Abstract][Full Text] [Related]
10. Circumferential strain acquired by CMR early after acute myocardial infarction adds incremental predictive value to late gadolinium enhancement imaging to predict late myocardial remodeling and subsequent risk of sudden cardiac death.
Holmes AA; Romero J; Levsky JM; Haramati LB; Phuong N; Rezai-Gharai L; Cohen S; Restrepo L; Ruiz-Guerrero L; Fisher JD; Taub CC; Di Biase L; Garcia MJ
J Interv Card Electrophysiol; 2017 Dec; 50(3):211-218. PubMed ID: 29143170
[TBL] [Abstract][Full Text] [Related]
11. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
Cui Q; Yu J; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.
Oda S; Utsunomiya D; Morita K; Nakaura T; Yuki H; Kidoh M; Hirata K; Taguchi N; Tsuda N; Shiraishi S; Namimoto T; Hirakawa K; Takashio S; Izumiya Y; Yamamuro M; Hokimoto S; Tsujita K; Ueda M; Yamashita T; Ando Y; Yamashita Y
Eur Radiol; 2017 Nov; 27(11):4631-4638. PubMed ID: 28477167
[TBL] [Abstract][Full Text] [Related]
13. Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Light-Chain Amyloidosis.
Wan K; Sun J; Yang D; Liu H; Wang J; Cheng W; Zhang Q; Zeng Z; Zhang T; Greiser A; Jolly MP; Han Y; Chen Y
Radiology; 2018 Jul; 288(1):73-80. PubMed ID: 29664336
[TBL] [Abstract][Full Text] [Related]
14. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis.
Hoffmann R; Altiok E; Friedman Z; Becker M; Frick M
Am J Cardiol; 2014 Oct; 114(7):1083-8. PubMed ID: 25212549
[TBL] [Abstract][Full Text] [Related]
15. Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis.
Aquaro GD; Pugliese NR; Perfetto F; Cappelli F; Barison A; Masci PG; Passino C; Emdin M
Int J Cardiovasc Imaging; 2014 Aug; 30(6):1105-15. PubMed ID: 24789582
[TBL] [Abstract][Full Text] [Related]
16. Myocardial deformation imaging by two-dimensional speckle-tracking echocardiography for prediction of global and segmental functional changes after acute myocardial infarction: a comparison with late gadolinium enhancement cardiac magnetic resonance.
Altiok E; Tiemann S; Becker M; Koos R; Zwicker C; Schroeder J; Kraemer N; Schoth F; Adam D; Friedman Z; Marx N; Hoffmann R
J Am Soc Echocardiogr; 2014 Mar; 27(3):249-57. PubMed ID: 24368027
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Myocardial Strain in Patients With Amyloidosis Using Cardiac Magnetic Resonance Feature Tracking.
Pandey T; Alapati S; Wadhwa V; Edupuganti MM; Gurram P; Lensing S; Jambhekar K
Curr Probl Diagn Radiol; 2017; 46(4):288-294. PubMed ID: 28063633
[TBL] [Abstract][Full Text] [Related]
18. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
Mordi I; Bezerra H; Carrick D; Tzemos N
JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
[TBL] [Abstract][Full Text] [Related]
19. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
[TBL] [Abstract][Full Text] [Related]
20. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
